CI Global Investments’s Novo Nordisk NVO Stock Holding History

CI Global Investments’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-605,442	Closed	-$14.6M	–	103
2017 Q3	$14.6M	Buy	+605,442	New	+$13.7M	0.26%	46
2015 Q4	–	Sell	-270,000	Closed	-$7.32M	–	141
2015 Q3	$7.32M	Sell	270,000 -130,000	-33%	-$3.68M	0.17%	87
2015 Q2	$11M	Hold	400,000	–	–	0.22%	87
2015 Q1	$10.7M	Hold	400,000	–	–	0.23%	83
2014 Q4	$8.46M	Hold	400,000	–	–	0.17%	92
2014 Q3	$9.52M	Hold	400,000	–	–	0.22%	96
2014 Q2	$9.24M	Hold	400,000	–	–	0.24%	94
2014 Q1	$9.13M	Sell	400,000 -75,000	-16%	-$1.6M	0.24%	92
2013 Q4	$8.78M	Buy	475,000 +75,000	+19%	+$1.31M	0.25%	95
2013 Q3	$6.77M	Sell	400,000 -250,000	-38%	-$4.2M	0.26%	108
2013 Q2	$10.1M	Buy	+650,000	New	+$10.8M	0.46%	77

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

CI Global Investments's NVO Position: Q4 2017 in Review

CI Global Investments sold out of Novo Nordisk (NVO) in Q4 2017, closing a stake of 605,442 shares — an estimated $14.6M sold.

CI Global Investments first reported a position in NVO in Q2 2013 and held it in 11 quarters. The position peaked at $14.6M in Q3 2017. 552 funds tracked by Wall St. Rank hold NVO as of Q4 2017.

CI Global Investments reported no remaining Novo Nordisk position as of Q4 2017 after selling out during the quarter.
CI Global Investments sold 605,442 Novo Nordisk shares in Q4 2017, an estimated $14.6M.
CI Global Investments first reported a position in Novo Nordisk in Q2 2013 and held it in 11 quarters.
CI Global Investments's Novo Nordisk position peaked at $14.6M in Q3 2017.
552 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2017.

Based on CI Global Investments's 13F filing for Q4 2017, filed 2 Feb 2018.